4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 31.48 Million AUD | -30.43% |
| 2023 | 45.25 Million AUD | 22.21% |
| 2022 | 37.03 Million AUD | 51.37% |
| 2021 | 24.46 Million AUD | 212.52% |
| 2020 | 7.82 Million AUD | 137.88% |
| 2019 | 3.29 Million AUD | 52.43% |
| 2018 | 2.15 Million AUD | 23.54% |
| 2017 | 1.74 Million AUD | 56.23% |
| 2016 | 1.11 Million AUD | 186.76% |
| 2015 | 390.03 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 19.84 Million AUD | -56.15% |
| 2024 Q1 | 8.6 Million AUD | -10.44% |
| 2024 Q4 | 8.69 Million AUD | 0.0% |
| 2024 Q2 | 10.74 Million AUD | 24.87% |
| 2024 Q3 | 8.69 Million AUD | -19.11% |
| 2023 Q3 | 7.73 Million AUD | -27.58% |
| 2023 FY | 45.25 Million AUD | 22.21% |
| 2023 Q1 | 8.32 Million AUD | -2.64% |
| 2023 Q4 | 9.6 Million AUD | 24.16% |
| 2023 Q2 | 10.68 Million AUD | 28.28% |
| 2022 Q1 | 6.28 Million AUD | -8.25% |
| 2022 Q2 | 7.76 Million AUD | 23.58% |
| 2022 Q4 | 8.55 Million AUD | 40.53% |
| 2022 FY | 37.03 Million AUD | 51.37% |
| 2022 Q3 | 6.08 Million AUD | -21.59% |
| 2021 Q3 | 4.14 Million AUD | -23.85% |
| 2021 FY | 24.46 Million AUD | 212.52% |
| 2021 Q2 | 5.44 Million AUD | 2.93% |
| 2021 Q1 | 5.29 Million AUD | 1.64% |
| 2021 Q4 | 6.84 Million AUD | 65.16% |
| 2020 Q1 | 2.35 Million AUD | 27.08% |
| 2020 Q3 | 4.7 Million AUD | 88.67% |
| 2020 Q4 | 5.2 Million AUD | 10.65% |
| 2020 FY | 7.82 Million AUD | 137.88% |
| 2020 Q2 | 2.49 Million AUD | 5.76% |
| 2019 Q4 | 1.85 Million AUD | 0.0% |
| 2019 Q2 | 1.29 Million AUD | 0.0% |
| 2019 Q1 | 1.29 Million AUD | 0.0% |
| 2019 FY | 3.29 Million AUD | 52.43% |
| 2019 Q3 | 1.85 Million AUD | 43.29% |
| 2018 FY | 2.15 Million AUD | 23.54% |
| 2017 FY | 1.74 Million AUD | 56.23% |
| 2016 FY | 1.11 Million AUD | 186.76% |
| 2015 FY | 390.03 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Adherium Limited | 267.7 Thousand AUD | -11660.72% |
| Aroa Biosurgery Limited | 66.09 Million AUD | 52.369% |
| Atomo Diagnostics Limited | 1.6 Million AUD | -1860.382% |
| Anteris Technologies Ltd | 69.14 Million AUD | 54.47% |
| Control Bionics Limited | 9.82 Million AUD | -220.416% |
| CardieX Limited | 16.64 Million AUD | -89.104% |
| Compumedics Limited | 26.88 Million AUD | -17.127% |
| Cochlear Limited | 1.17 Billion AUD | 97.32% |
| CleanSpace Holdings Limited | 11.35 Million AUD | -177.163% |
| Cyclopharm Limited | 13.38 Million AUD | -135.29% |
| EMVision Medical Devices Ltd | 12.83 Million AUD | -145.323% |
| Nova Eye Medical Limited | 23.99 Million AUD | -31.237% |
| HeraMED Limited | 6.78 Million AUD | -364.16% |
| Imricor Medical Systems, Inc. | -1.11 Million AUD | 2921.536% |
| ImpediMed Limited | 28.04 Million AUD | -12.278% |
| InhaleRx Limited | 2.59 Million AUD | -1115.341% |
| LBT Innovations Limited | 1.1 Million AUD | -2744.065% |
| Micro-X Limited | 18.76 Million AUD | -67.788% |
| Neurotech International Limited | 8.75 Million AUD | -259.638% |
| OncoSil Medical Limited | 12.03 Million AUD | -161.497% |
| PolyNovo Limited | 34.92 Million AUD | 9.845% |
| Respiri Limited | 8.03 Million AUD | -291.84% |
| SomnoMed Limited | 58.97 Million AUD | 46.613% |
| Universal Biosensors, Inc. | 20 Million AUD | -57.417% |
| Uscom Limited | 5.52 Million AUD | -470.354% |
| Visioneering Technologies, Inc. | 9.63 Million AUD | -226.811% |